scholarly journals Use of anti-idiotypic antibodies to establish that monoclonal antibody 7H11D6 binds to the alpha 2-macroglobulin receptor recognition site.

1988 ◽  
Vol 263 (14) ◽  
pp. 6709-6714 ◽  
Author(s):  
I J Isaacs ◽  
J P Steiner ◽  
P A Roche ◽  
S V Pizzo ◽  
D K Strickland
1982 ◽  
Vol 203 (2) ◽  
pp. 405-411 ◽  
Author(s):  
F Van Leuven ◽  
P Marynen ◽  
J J Cassiman ◽  
H Van den Berghe

The unique steric type of inhibition of endopeptidases by human alpha 2-macroglobulin (alpha 2-M) and the inactivation of the latter by methylamine were examined in relation to the internal thioesters in alpha 2M. The present results confirm our previous findings that disruption of the internal thioesters, is not in itself sufficient to cause the conformational change of alpha 2M typical of alpha 2-M-proteinase complexes; the electrophoretically slow form of alpha 2M with [14C]methylamine incorporated was isolated. Moreover, this group is stabilized by derivatization of the exposed cysteine thiol groups. Cyanylation with 2,4-dinitrophenyl thiocyanate during the methylamine reaction was the most effective procedure, yielding essentially only slow-form alpha 2M. Other thiol-specific reagents were less effective. When allowed to react with trypsin the cyanylated derivative (slow-form alpha 2M with thioesters broken) produced anomalous complexes; only half the expected amount of trypsin was bound, whereas the complexes were fully inhibited by soya-bean trypsin inhibitor and were proteolytically active. Despite this, the anomalous complexes were recognized by two highly specific probes: the fibroblast alpha 2M-complex receptor and the monoclonal antibody (F2B2) directed against the receptor-recognition site on alpha 2M complexes. The results show that the internal thioesters in alpha 2M are necessary for the conformational change producing sterically inhibited endoproteinase complexes, but do not participate as such in receptor-mediated endocytosis of these complexes.


2017 ◽  
Vol 114 (4) ◽  
pp. 770-775 ◽  
Author(s):  
Xiangxi Wang ◽  
Ling Zhu ◽  
Minghao Dang ◽  
Zhongyu Hu ◽  
Qiang Gao ◽  
...  

Hepatitis A virus (HAV) infects ∼1.4 million people annually and, although there is a vaccine, there are no licensed therapeutic drugs. HAV is unusually stable (making disinfection problematic) and little is known of how it enters cells and releases its RNA. Here we report a potent HAV-specific monoclonal antibody, R10, which neutralizes HAV infection by blocking attachment to the host cell. High-resolution cryo-EM structures of HAV full and empty particles and of the complex of HAV with R10 Fab reveal the atomic details of antibody binding and point to a receptor recognition site at the pentamer interface. These results, together with our observation that the R10 Fab destabilizes the capsid, suggest the use of a receptor mimic mechanism to neutralize virus infection, providing new opportunities for therapeutic intervention.


2009 ◽  
Vol 38 (3) ◽  
pp. 204-211 ◽  
Author(s):  
JAMES P. TAM ◽  
YAO-ZHONG LIN ◽  
WEN LIU ◽  
DE-XIN WANG ◽  
XIAO-HONG KE ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document